Pharmaceutical Perspectives of Cancer Therapeutics 2009
DOI: 10.1007/978-1-4419-0131-6_8
|View full text |Cite
|
Sign up to set email alerts
|

Application of Nanobiotechnology in Cancer Therapeutics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
4
0

Year Published

2011
2011
2013
2013

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 56 publications
1
4
0
Order By: Relevance
“…Localization at the level of mitochondria is realized by the presence of extra nuclear DNA [25]. These data are consistent with other experiments which underline that silver nanoparticles penetrate the cells membrane and can be used for the detection of the SERS signal [26,27]. Their aggregation is possible in the growth medium and due to their increased size endocytosis is assumed [28].…”
Section: Resultssupporting
confidence: 83%
“…Localization at the level of mitochondria is realized by the presence of extra nuclear DNA [25]. These data are consistent with other experiments which underline that silver nanoparticles penetrate the cells membrane and can be used for the detection of the SERS signal [26,27]. Their aggregation is possible in the growth medium and due to their increased size endocytosis is assumed [28].…”
Section: Resultssupporting
confidence: 83%
“…The attributes of organic and inorganic nanoparticles, such as small size, composition, surface structure, solubility, shape and aggregation allow for unlimited modifications of their basic properties such as diffusivity, targeting, stability, solubility, half-life in circulatory system and controlled drug release. Due to such unique features, nanoparticles have the advantage over traditional therapeutic and diagnostic agents [1][2][3][4]. Nanoresearch is focused on many life-sciences including applications in environmental, health and safety sciences.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, it can be expected that an ideal nanoparticular delivery system that can significantly overcome MDR would be dependent on the high efficiency of cellular entry of the nanoparticles and subsequent rapid release of the cytotoxic drug intracellularly that should be sufficiently high to induce cytotoxicity. Gold nanoparticles (AuNPs), which are known to be inert, have shown advantages and significant progress in the delivery of small molecules to large biomacromolecules, including DNA, siRNA, and proteins. On the other hand, recent studies have indicated that AuNPs act as good quenchers of many fluorescence donors, due to the nanosurface energy transfer (NSET) effect. This may render AuNPs as the base of a fluorescent “nanoprobe”, particularly useful in the trafficking of intracellular drug release, by monitoring changes in fluorescence. In this study, we developed a drug delivery system by tethering doxorubicin onto the surface of AuNPs with a poly(ethylene glycol) spacer via an acid-labile linkage (Scheme ), which can significantly overcome P-gp-mediated drug resistance by a combination of enhanced doxorubicin cellular entry and a responsive intracellular release of doxorubicin in acidic organelles.…”
mentioning
confidence: 99%